These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 10837559)

  • 21. Clinical pharmacology of HIV protease inhibitors: focus on saquinavir, indinavir, and ritonavir.
    Hoetelmans RM; Meenhorst PL; Mulder JW; Burger DM; Koks CH; Beijnen JH
    Pharm World Sci; 1997 Aug; 19(4):159-75. PubMed ID: 9297727
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protease inhibitors for the treatment of human immunodeficiency virus infection.
    Kakuda TN; Struble KA; Piscitelli SC
    Am J Health Syst Pharm; 1998 Feb; 55(3):233-54. PubMed ID: 9492254
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Once-daily dosing of saquinavir and low-dose ritonavir in HIV-1-infected individuals: a pharmacokinetic pilot study.
    van Heeswijk RP; Veldkamp AI; Mulder JW; Meenhorst PL; Lange JM; Beijnen JH; Hoetelmans RM
    AIDS; 2000 Jun; 14(9):F103-10. PubMed ID: 10894270
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential inhibition of cytochrome P450 isoforms by the protease inhibitors, ritonavir, saquinavir and indinavir.
    Eagling VA; Back DJ; Barry MG
    Br J Clin Pharmacol; 1997 Aug; 44(2):190-4. PubMed ID: 9278209
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ritonavir/saquinavir plus one nucleoside reverse transcriptase inhibitor (NRTI) versus indinavir plus two NRTIs in protease inhibitor-naive HIV-1-infected adults (IRIS study).
    Florence E; Dreezen C; Desmet P; Smets E; Fransen K; Vandercam B; Pelgrom J; Clumeck N; Colebunder R
    Antivir Ther; 2001 Dec; 6(4):255-62. PubMed ID: 11878407
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activity of a ritonavir plus saquinavir-containing regimen in patients with virologic evidence of indinavir or ritonavir failure.
    Deeks SG; Grant RM; Beatty GW; Horton C; Detmer J; Eastman S
    AIDS; 1998 Jul; 12(10):F97-102. PubMed ID: 9677159
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of saquinavir/ritonavir on P-glycoprotein activity in healthy volunteers using digoxin as a probe.
    Schmitt C; Kaeser B; Riek M; Bech N; Kreuzer C
    Int J Clin Pharmacol Ther; 2010 Mar; 48(3):192-9. PubMed ID: 20197013
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The safety and antiviral effect of protease inhibitors in children.
    Temple ME; Koranyi KI; Nahata MC
    Pharmacotherapy; 2001 Mar; 21(3):287-94. PubMed ID: 11253853
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug interactions of HIV protease inhibitors.
    Malaty LI; Kuper JJ
    Drug Saf; 1999 Feb; 20(2):147-69. PubMed ID: 10082072
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetic interaction between rifampicin and the once-daily combination of saquinavir and low-dose ritonavir in HIV-infected patients with tuberculosis.
    Ribera E; Azuaje C; Lopez RM; Domingo P; Curran A; Feijoo M; Pou L; Sánchez P; Sambeat MA; Colomer J; Lopez-Colomes JL; Crespo M; Falcó V; Ocaña I; Pahissa A
    J Antimicrob Chemother; 2007 Apr; 59(4):690-7. PubMed ID: 17307771
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interaction of anti-HIV protease inhibitors with the multidrug transporter P-glycoprotein (P-gp) in human cultured cells.
    Washington CB; Duran GE; Man MC; Sikic BI; Blaschke TF
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Nov; 19(3):203-9. PubMed ID: 9803961
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of desipramine hydroxylation (Cytochrome P450-2D6) in vitro by quinidine and by viral protease inhibitors: relation to drug interactions in vivo.
    von Moltke LL; Greenblatt DJ; Duan SX; Daily JP; Harmatz JS; Shader RI
    J Pharm Sci; 1998 Oct; 87(10):1184-9. PubMed ID: 9758674
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human immunodeficiency virus type 1 protease inhibitors.
    McDonald CK; Kuritzkes DR
    Arch Intern Med; 1997 May; 157(9):951-9. PubMed ID: 9140265
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Simultaneous determination of the HIV protease inhibitors indinavir, amprenavir, saquinavir, ritonavir, nelfinavir and the non-nucleoside reverse transcriptase inhibitor efavirenz by high-performance liquid chromatography after solid-phase extraction.
    Marzolini C; Telenti A; Buclin T; Biollaz J; Decosterd LA
    J Chromatogr B Biomed Sci Appl; 2000 Mar; 740(1):43-58. PubMed ID: 10798293
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HIV protease inhibitors, saquinavir, indinavir and ritonavir: inhibition of CYP3A4-mediated metabolism of testosterone and benzoxazinorifamycin, KRM-1648, in human liver microsomes.
    Inaba T; Fischer NE; Riddick DS; Stewart DJ; Hidaka T
    Toxicol Lett; 1997 Dec; 93(2-3):215-9. PubMed ID: 9486958
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Delavirdine: clinical pharmacokinetics and drug interactions.
    Tran JQ; Gerber JG; Kerr BM
    Clin Pharmacokinet; 2001; 40(3):207-26. PubMed ID: 11327199
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of CYP3A4-HIV-1 protease drugs interactions by computational methods for Highly Active Antiretroviral Therapy in HIV/AIDS.
    Jayakanthan M; Chandrasekar S; Muthukumaran J; Mathur PP
    J Mol Graph Model; 2010 Jan; 28(5):455-63. PubMed ID: 19931478
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Salvage therapy with regimens containing ritonavir and saquinavir in extensively pretreated HIV-infected patients.
    Fätkenheuer G; Hoetelmans RM; Hunn N; Schwenk A; Franzen C; Reiser M; Jütte A; Rockstroh J; Diehl V; Salzberger B
    AIDS; 1999 Aug; 13(12):1485-9. PubMed ID: 10465071
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of antiretrovirals in pregnant women.
    Mirochnick M; Capparelli E
    Clin Pharmacokinet; 2004; 43(15):1071-87. PubMed ID: 15568888
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Simultaneous determination of the five HIV-protease inhibitors: amprenavir, indinavir, nelfinavir, ritonavir, and saquinavir in human plasma by solid-phase extraction and column liquid chromatography.
    Poirier JM; Radembino N; Robidou P; Jaillon P
    Ther Drug Monit; 2000 Aug; 22(4):465-73. PubMed ID: 10942189
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.